SynOx Therapeutics
Entity

  • SynOx Therapeutics

    Created in 2020
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    2,067

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    8, 7 Wilton Terrace, Dublin, Ireland

    Dublin

    Ireland

  • Employees

    Scale: 2-10

    Estimated: 18

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    6 months ago
Description
  • Value proposition

    Our mission is to focus on the unmet clinical needs of patients
    suffering from Tenosynovial Giant Cell Tumours (TGCT)

    SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.

Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics